Follow the people · Insider

HT

Helen Torley

Insider · President and CEO · HALO

Helen Torley files insider transactions with the SEC as a president and ceo of Halozyme Therapeutics (HALO). We hold 19 disclosed purchases and sales filed since 31 August 2011, 4 of them in the last 90 days.

  • Files forHALO
  • Disclosed buys and sells19 in all, 4 in the last 90 days
  • Last disclosure19 August 2026

Positions held

4 posts we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 6 January 201419 August 2026President and CEO · Halozyme Therapeutics (HALO)562 Form 4 lines · source: SEC Form 4
  • Filed 15 May 201825 May 2021Director · Quest Diagnostics (DGX)7 Form 4 lines · source: SEC Form 4
  • Filed 22 January 20151 September 2016Director · Relypsa (RLYP)11 Form 4 lines · source: SEC Form 4
  • Filed 29 August 20111 October 2013EVP, Chief Commercial Officer · Onyx Pharmaceuticals (ONXX)46 Form 4 lines · source: SEC Form 4

Everything they disclosed

120 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.